Cargando…
Natural products target glycolysis in liver disease
Mitochondrial dysfunction plays an important role in the occurrence and development of different liver diseases. Oxidative phosphorylation (OXPHOS) dysfunction and production of reactive oxygen species are closely related to mitochondrial dysfunction, forcing glycolysis to become the main source of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469892/ https://www.ncbi.nlm.nih.gov/pubmed/37663261 http://dx.doi.org/10.3389/fphar.2023.1242955 |
_version_ | 1785099548557836288 |
---|---|
author | Li, Shenghao Hao, Liyuan Hu, Xiaoyu |
author_facet | Li, Shenghao Hao, Liyuan Hu, Xiaoyu |
author_sort | Li, Shenghao |
collection | PubMed |
description | Mitochondrial dysfunction plays an important role in the occurrence and development of different liver diseases. Oxidative phosphorylation (OXPHOS) dysfunction and production of reactive oxygen species are closely related to mitochondrial dysfunction, forcing glycolysis to become the main source of energy metabolism of liver cells. Moreover, glycolysis is also enhanced to varying degrees in different liver diseases, especially in liver cancer. Therefore, targeting the glycolytic signaling pathway provides a new strategy for the treatment of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis associated with liver cancer. Natural products regulate many steps of glycolysis, and targeting glycolysis with natural products is a promising cancer treatment. In this review, we have mainly illustrated the relationship between glycolysis and liver disease, natural products can work by targeting key enzymes in glycolysis and their associated proteins, so understanding how natural products regulate glycolysis can help clarify the therapeutic mechanisms these drugs use to inhibit liver disease. |
format | Online Article Text |
id | pubmed-10469892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104698922023-09-01 Natural products target glycolysis in liver disease Li, Shenghao Hao, Liyuan Hu, Xiaoyu Front Pharmacol Pharmacology Mitochondrial dysfunction plays an important role in the occurrence and development of different liver diseases. Oxidative phosphorylation (OXPHOS) dysfunction and production of reactive oxygen species are closely related to mitochondrial dysfunction, forcing glycolysis to become the main source of energy metabolism of liver cells. Moreover, glycolysis is also enhanced to varying degrees in different liver diseases, especially in liver cancer. Therefore, targeting the glycolytic signaling pathway provides a new strategy for the treatment of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis associated with liver cancer. Natural products regulate many steps of glycolysis, and targeting glycolysis with natural products is a promising cancer treatment. In this review, we have mainly illustrated the relationship between glycolysis and liver disease, natural products can work by targeting key enzymes in glycolysis and their associated proteins, so understanding how natural products regulate glycolysis can help clarify the therapeutic mechanisms these drugs use to inhibit liver disease. Frontiers Media S.A. 2023-08-17 /pmc/articles/PMC10469892/ /pubmed/37663261 http://dx.doi.org/10.3389/fphar.2023.1242955 Text en Copyright © 2023 Li, Hao and Hu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Li, Shenghao Hao, Liyuan Hu, Xiaoyu Natural products target glycolysis in liver disease |
title | Natural products target glycolysis in liver disease |
title_full | Natural products target glycolysis in liver disease |
title_fullStr | Natural products target glycolysis in liver disease |
title_full_unstemmed | Natural products target glycolysis in liver disease |
title_short | Natural products target glycolysis in liver disease |
title_sort | natural products target glycolysis in liver disease |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469892/ https://www.ncbi.nlm.nih.gov/pubmed/37663261 http://dx.doi.org/10.3389/fphar.2023.1242955 |
work_keys_str_mv | AT lishenghao naturalproductstargetglycolysisinliverdisease AT haoliyuan naturalproductstargetglycolysisinliverdisease AT huxiaoyu naturalproductstargetglycolysisinliverdisease |